Sponsor: Ohio State University
Sponsor Study ID: 2020C0211
Study Title: A Phase Ib Trial of Zanubrutinib in Combination with R CHOP (ZaRCHOP) for Patients with Newly Diagnosed Diffuse Large B Cell Lymphoma
CTO #: 103293
NCT Number: NCT04850495
Phase: I
Protocol Type: Treatment
Age Group: Adults
Disease Sites: Non-Hodgkin's Lymphoma
Study Objectives: Determine the RP2D and safety of zanubrutinib in combination with R-CHOP (ZaR CHOP) for patients with previously untreated DLBCL.